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ABSTRACT 
Background: Menopause is associated with an array of metabolic 
changes which results into the appearance of inflammatory conditions. 
Objectives: The study evaluated the levels of some inflammatory 
markers; C-reactive protein (CRP), rheumatoid factor, erythrocyte 
sedimentation rate (ESR) and uric acid. The muscle markers evaluated 
were creatine kinase (CK) and aspartate transaminase (AST) as well as 
body mass index (BMI) and blood pressure (Bp) in premenopausal and  
postmenopausal women. Method: The study is a case-controlled study involving 50 
premenopausal and 50 postmenopausal women in Nnewi metropolis. In both study groups, 
anthropometric measurements including body mass index (Kg/m
2
) and blood pressure 
(mmHg) were carried out. Serum levels of uric acid, creatine kinase, C-reactive protein, 
aspartate transaminase, rheumatoid factor and erythrocyte sedimentation rate were measured 
using appropriate techniques. Results: The result showed significant increase (p<0.05) in the 
mean serum levels of uric acid (μmol/L), CRP (mg/L), ESR mm/hr, and AST IU/L but no 
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significant change was observed in  creatine kinase in post menopausal women. A significant 
positive relationship was observed between CRP and BMI (r = 0.562; p<0.01), CRP and ESR 
(r = 0.553; p<0.01). The prevalence of positive rheumatoid factor among postmenopausal 
women was determined as 16%. Conclusion: The study concluded that in postmenopausal 
women, there is significant increase in the levels of CRP, ESR and uric acid. There is also a 
significant positive relationship between CRP, ESR and BMI indicating that the degree of 
changes in metabolites and obesity might have a role in the mediation of inflammation in post 
menopausal women.  
 
KEYWORDS: Premenopausal women, postmenopausal women, inflammatory markers 
 
INTRODUCTION 
Menopause is associated with an array of metabolic changes which results into the 
appearance of inflammatory conditions. Menopause occurs in most women between 45 and 
55 years of age, although it may begin as early as age 40 or be delayed to the late 50s. 
Menopause has been considered to be premature when it occurs before 40 years of age.
[1] 
The 
hormonal changes that occur during menopause may modulate certain diseases.
[2]
 The most 
common types of arthritis seen in women after menopause are osteoarthritis, rheumatoid 
arthritis and gouty arthritis to a lesser degree. The culminating effect of these conditions is 
arthralgia or severe joint pain.
[3]
 Menopause is associated with a natural decline in estrogen, 
increase visceral fat mass, decrease bone mass density, muscle mass, and strength.
[4]
 Muscle 
loss is a natural consequence of aging, inactivity, and their associated metabolic dysfunction, 
but it is strongly accelerated in critical illness such as organ failure, sepsis, or cancer.
[5]
 
Therefore, evaluation of these conditions will provide an understanding into the cause and 
possible management of these conditions. 
 
MATERIALS AND METHODS 
The ethical approval for the research was obtained from the ethical Committee, Faculty of 
Health Sciences, NAU. Informed consent was obtained from the subjects using questionnaire. 
Blood specimen was collected for the estimation of the serum levels of C-reactive protein, 
uric acid, rheumatoid factor and the activities of aspartate aminotransferase
[8]
 and creatine 
kinase.
[6,7,8,9]
 The erythrocyte sedimentation rate was determined using whole blood.
[10] 
Statistical Package for Social Science (SPSS) version 20.0 was used for the analysis of the 
results obtained. Data collected was subjected to statistical analysis using student t-test and 
correlation (r). Values were deemed significant at p<0.05 and p<0.01. 
www.wjpls.org 
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RESULTS 
The mean level of Body Mass Index and blood pressure were shown in table 1 while Table 2 
shows the mean serum level of the inflammatory and muscle markers in Premenopausal and 
Postmenopausal Women. Table 3 shows the relationship between the markers in 
postmenopausal women. Eight out of the fifty women were Rheumatoid factor-positive 
resulting in 16% positivity. 
 
Table 1: Anthropometric Data in the Premenopausal and Postmenopausal Women 
PARAMETERS 
PRE-MENOPAUSAL 
MEAN ± SD 
POST-MENOPAUSAL 
MEAN ± SD 
t-test p-Value 
Body Mass Index 
(kgm
-2
) 
22.59 ± 3.37 30.70 ± 6.16 -8.173 0.000* 
Systole (mmHg) 121.70  ± 10.95 154.36 ± 27.42 -7.821 0.000* 
Diastole (mmHg) 75.70 ± 9.03 90.30 ± 12.24 -6.787 0.000* 
N = 50 
* = Significant at p<0.05 
 
Table 2: Serum levels of inflammatory and muscle markers in Premenopausal and 
Postmenopausal Women. 
PARAMETERS 
PRE-MENOPAUSAL 
MEAN ± SD 
POST-MENOPAUSAL 
MEAN ± SD 
t-test P-Value 
C-Reactive Protein 
(mg/L) 
0.02 ± 0.04 0.06 ± 0.05 -4.894 0.000* 
Uric acid (μmol/L) 191.86 ± 47.50 265.56 ± 77.10 -5.755 0.000* 
ESR (mm/hr) 14.26 ± 8.31 32.20 ± 18.85 -6.158 0.000* 
Creatine kinase (U/L) 155.47 ± 88.31 156.26 ± 117.13 -0.038 0.970 
AST (U/L) 15.64 ± 4.96 18.99 ± 7.75 -2.576 0.011* 
N = 50 
* = Significant at p<0.05 
 
Table 3: Relationship between the markers in postmenopausal women. 
PARAMETERS r p-value 
C-reactive protein and Body mass index 0.562 0.000** 
C-reactive protein and Erythrocyte sedimentation rate 0.553 0.000** 
Body mass index and Erythrocyte sedimentation rate 0.306 0.031* 
Erythrocyte sedimentation rate and Uric acid 0.302 0.033* 
N = 50 
** = Significant at p<0.01 
* = Significant at p<0.05 
www.wjpls.org 
 
308 
Oluboyo et al.                                         World Journal of Pharmaceutical and Life Sciences 
 
Figure 1: Rheumatoid factor in premenopausal and postmenopausal women. 
 
DISCUSSION 
Metabolic changes and the appearance of many diseases tend to occur following the onset of 
menopause. These changes include inflammation and muscular damage.
[11,12,13,14]
 It was 
observed that the systolic and diastolic blood pressure increase significantly between 
premenopausal and postmenopausal women. This increase in blood pressure has been 
associated with increase in age which reduces the elasticity of blood vessels as well as 
associated increase in cholesterol level seen in postmenopausal women which leads to 
vascular stenosis.
[15,16,17,18]
 Previous studies have also recorded marked differences in both 
systolic and diastolic blood pressure with the onset of menopause.
[12,19,20]
 The body mass 
index (BMI) also showed a significant increase in the mean levels in postmenopausal women 
and this agrees with other researchers.
[21]  
 
The CRP, ESR and uric acid showed significant increases in the postmenopausal women 
compared with the premenopausal women and these have been supported by other 
works.
[22,23] 
There was positive correlation between BMI and CRP levels in postmenopausal 
women. There are several mechanisms which may link adiposity with elevated CRP levels. 
Adiposity has been shown to be a significant predictor of plasma CRP in post-menopausal 
women.
[23] 
The increase in uric acid in postmenopausal women has been supported by a work 
on menopause, postmenopausal hormone use and serum uric acid levels in women.
[24]
 The 
work revealed that menopause was associated with higher serum uric acid levels and 
postmenopausal hormone use was associated with a lower serum uric acid level among 
postmenopausal women, although, the mechanism is not known.
[24]
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The muscle marker Creatine kinase showed no change between premenopausal and post 
menopausal women, whereas aspartate transaminase activity was increased in 
postmenopausal women. This is in harmony with the work which attributed this rise partly to 
the liver.
[25]
  Some authors suggested that the loss of muscle strength coincides with the 
estrogen deficit of menopause.
[26]
 
 
It was also observed that the percentage prevalence of positive test for Rheumatoid Factor is 
16% within the postmenopausal group. This agreed with the work carried out on prevalence 
of rheumatoid factor in Nigeria.
[27]
 The study found the percentage prevalence in Isheri to be 
17% and Igbo-Oro to be 19%. 
 
CONCLUSION 
The study concluded that in postmenopausal women, there is significant increase in the levels 
of CRP, ESR and uric acid. There is also a significant positive relationship between CRP, 
ESR and BMI indicating that the degree of changes in metabolites and obesity might have a 
role in the mediation of inflammation in post menopausal women. 
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